By 1994, national health expenditures had reached nearly 14% of the U.S. gross domestic product.1 The failure of the Clinton administration's proposed health care reform plan accelerated the rise of managed care, under which private insurers attempted to regulate health care delivery to reduce costs. In 1998, concerned about the size and potential financial risk associated with its faculty practice plans, the University of Pittsburgh (Pitt) transferred these plans and its hospital management functions to an independent nonprofit corporation, the University of Pittsburgh Medical Center (UPMC). A series of interrelated agreements defined the close interaction and coordination that both institutions saw as essential to their long-term success, including a substantial number of shared board members and UPMC's ongoing financial support of Pitt's medical school (Figure 1).
UPMC and the Pitt School of Medicine (SOM) have thrived under this model (Table 1). Today, UPMC is western Pennsylvania's largest employer2 and has expanded its clinical operations to Italy, Ireland, and Qatar. UPMC reported revenues of $6.8 billion in fiscal year 2007, with $618 million in net income. Pitt, led by its medical school faculty, became one of the nation's top 10 recipients of National Institutes of Health (NIH) research support in 1997 and has progressed within that status since, even during the recent period of NIH budgetary stagnation.3 The NIH process is the major national, peer-reviewed, objective metric commonly used to assess overall academic quality in a biomedical-research-focused institution.
The paradigm underlying the Pitt–UPMC relationship, which is embodied in but extends well beyond the terms of the formal affiliation agreements, is rooted in one core principle: In an academic health center (AHC), research and clinical success are synergistic and interdependent. In-depth, committed, strategic collaboration between the clinical and the academic enterprises will enhance the success of both beyond that which would occur with an investment in either alone. 4
For Pitt and UPMC, the entry point for implementing this principle was to invest clinical revenue in medical school research, including facilities, equipment, and faculty start-up packages. The SOM complemented this investment by developing infrastructure to encourage and sustain new research initiatives, including technologically rich core facilities and faculty incentives for research productivity. With such an intense, focused resource commitment, faculty members were able to leverage those investments into funded grants from NIH and other federal and private sources. This funding and the ensuing faculty success in reporting their findings promoted the visibility of not just the medical school but the entire university. At the same time, UPMC continued to grow, with a significant share of increased volume attributable to the faculty-practice-plan physicians, stimulating the strong financial performance that is the cycle's entry point (Figure 2). To operationalize the principle, however, UPMC required (1) sufficient resources and (2) a willingness to reinvest them in the SOM's academic mission. Both of these conditions were present.
When faced with the volatile health care climate of the 1980s, during which corporate models were increasingly applied to health care in an effort to control declining revenues and spiraling costs,5 Pitt and UPMC realized that crisis could equal opportunity if both were willing to act boldly. This article describes that process.
The Pilot Project: Western Psychiatric Institute and Clinic
As Wartman6 noted, although the perception is that AHCs have a variety of organizational models, in fact, two prototypes dominate: (1) the fully integrated model through which all functions—academic, clinical, and research—report to one person and one board, and (2) the divided model, where the academic and clinical functions are managed separately and report to different boards. Pitt and UPMC technically fall into the divided model but with a much more robust and structured financial interface than is typical with that model. The current structure is the culmination of a 20-plus-year evolution, which began in the unlikely setting of Western Psychiatric Institute and Clinic (WPIC), a state psychiatric hospital built by the Commonwealth of Pennsylvania in 1942 and transferred to Pitt's fiscal and operational management in 1949.
Until the mid-1980s, the Pitt SOM was recognized mainly as a regional institution with modest research activity. At the time, Pitt's teaching hospitals included five financially and legally independent private nonprofit hospitals (Children's Hospital of Pittsburgh, Eye & Ear Hospital of Pittsburgh, Magee-Womens Hospital, Montefiore Hospital, Presbyterian University Hospital) as well as WPIC, all clustered on or near the Pitt campus. These facilities served as teaching sites for medical students and residents and practice sites for faculty.
Pittsburgh is noted for its private foundations, most of them outgrowths of the city's industrial success, and their role in community development. When the Richard King Mellon Foundation was created in 1947, one of its priorities was to establish a first-rate health center in Pittsburgh.7 Progress toward this farsighted goal was painfully slow, and the Pitt-affiliated hospitals remained largely undistinguished. By the early 1970s, the state was sufficiently concerned to threaten major funding cuts because of WPIC's lack of responsiveness to new developments in psychiatry and to the mental health needs of the region's citizens.
In response, Pitt sought and received $5 million from the Richard King Mellon Foundation to recruit a chair of psychiatry who could bring the department into the modern era of biological psychiatry and also serve as WPIC director. From the outset, the vision of the new chair of psychiatry and WPIC director, one of us (T.P.D.), was to apply emerging knowledge from neuroscience, psychopharmacology, epidemiology, and genetics to the field of psychiatry in a truly interdisciplinary approach and to build a department around rigorous clinical research and what is now called evidence-based clinical practice.
By applying business principles to the department and hospital, the department chair/WPIC director implemented an organizational structure and management model that became a scalable template for UPMC. He negotiated two essential components with Pitt: (1) control of the hospital's clinical revenues so that he could reinvest any excess margin from improved productivity in faculty recruitment, patient care, and research, and (2) retention of an amount of funding equal to the indirect costs from NIH grants (which were then modest). With these agreements in place, he controlled all revenues, although the department was “on its own bottom,” without Pitt resources.
The department used its revenue for improvements to clinical facilities, infrastructure to support the growing research portfolio, incentive payments to faculty who secured grant funding, and recruitment of new faculty from fields including neuroscience, imaging, genetics, and social science. The department also created an Office of Research to provide technical assistance in grantsmanship (e.g., study design, statistical power calculation and analytic design, budgeting, responsiveness to NIH priorities) and mandated a presubmission peer-review process for all grant proposals. As research prospered, so did WPIC's clinical volume and community interaction, which became a de facto marketing strategy. Between 1974 and 1982, the department's full-time faculty grew from 36 to nearly 150. Within 10 years, Pitt's Department of Psychiatry was one of the nation's top three in NIH funding and was a driving force in Pitt's overall NIH support, which was approximately $3.4 million in 1980, placing Pitt 36th among NIH grant recipients.
The Department of Psychiatry/WPIC financial structure came to define the UPMC business model, whereas the department's interdisciplinarity was a model for the SOM's ensuing success.
From a Loose Consortium of Hospitals to UPMC
From the mid-1970s through the mid-1980s, U.S. health care costs skyrocketed, fueled by inflation, Medicare and Medicaid growth, fee-for-service-based reimbursement under private insurance, cost-based reimbursement under public insurance, and technological advances that increased hospital use and costs. However, this reimbursement structure enabled hospitals to recover all costs; many hospitals, including those affiliated with AHCs, became cash cows that fueled faculty and research growth.8
Pitt was still affiliated with the aforementioned five independent teaching hospitals, which had loosely organized as a voluntary consortium, the University Health Center of Pittsburgh (UHCP). The Pitt-controlled WPIC was also a UHCP member. The consortium's goal was to support members' common objectives in advancing teaching, research, and patient care. In addition, the SOM's faculty, under Pitt auspices, had developed departmental practice plans to subsidize their departments by billing patients in UHCP hospitals and outpatient clinics; each plan was an independent corporation.
In 1982, the Pitt administration, having witnessed the Department of Psychiatry's success, asked the department chair/WPIC director to serve as associate senior vice chancellor for the health sciences and, in 1984, as senior vice chancellor (SVC) responsible for all six health sciences schools (Medicine, Dental Medicine, Health and Rehabilitation Sciences, Nursing, Pharmacy, and Public Health). The new SVC, one of us (T.P.D.), set out to apply the WPIC model to the entire SOM, including retention of all revenues, and to plan interdisciplinary centers of excellence in key areas such as cancer and transplantation, a promising but still high-risk, highly speculative research area.
In 1983, new legislation changed Medicare from cost-based reimbursement to flat-rate prospective payment, potentially constraining hospital use and income. The new system required more efficient operations for hospitals to survive and heralded a spate of hospital mergers nationwide. In 1984, two UHCP hospitals, Presbyterian-University and Eye & Ear, tried unsuccessfully to merge. After negotiations failed, Pitt approached Eye & Ear with a management offer. The hospital agreed to enter into a shared management arrangement with Pitt, under the direction of the SVC management team, and to include two-thirds Pitt-appointed trustees on its board.
Then, in 1985, with seed funding from the Richard King Mellon Foundation, Pitt recruited a highly regarded senior scientist from the National Cancer Institute (NCI) to direct what would become the University of Pittsburgh Cancer Institute (UPCI). In 1990, UPCI became the youngest cancer center to be designated an NCI comprehensive cancer center. (To receive this designation, a cancer center must engage in research across the full spectrum from basic science to cancer prevention and control studies including clinical trials; provide outstanding clinical care; and serve as a community resource for cancer information, education, and outreach.)
UPCI and what eventually became the Thomas E. Starzl Transplantation Institute were pilot tests for a foundation of the UPMC–Pitt health sciences model—interdisciplinary, interinstitutional centers of excellence. These centers integrate the best research, clinical care, and teaching from multiple departments, hospitals, and institutions under a matrix management structure (see List 1). Each center director reports to the SVC, assuring equal status for all participating entities. Entities opting into such centers must provide financial support for the center's core services and discretionary funds for research and development.
Also in 1985, recognizing that UHCP had failed to coordinate members' interests, the Presbyterian-University Hospital board commissioned the SVC management team to review options for improving and strengthening the organization. The resulting concept paper proposed an organizational relationship among Presbyterian-University Hospital, Eye & Ear Hospital, WPIC, and Pitt, with centralized management of the clinical facilities under a single administrative structure that remained linked to Pitt's academic mission. The concept paper further proposed a shared governance and management model, with equal community and Pitt representation and stronger faculty input into planning and decision making. The model linked the clinical enterprise to Pitt through board membership (Pitt would appoint half of Presbyterian's 24-member board) and led to the creation of Pitt's Medical and Health Care Division (MHCD) as the centralized management entity for all of these facilities under the SVC's direction. The hospitals adopted the model in July 1986, and Pitt named one of us (J.A.R.) executive vice president of the new division.
MHCD, now with management responsibility for Presbyterian and its increasingly successful transplantation program, focused on improving the financial performance of the facilities it managed. MHCD expanded Presbyterian and integrated the management of Presbyterian, Eye & Ear, and WPIC. This consolidation enabled MHCD to invest $230 million to expand the transplantation program and provide space for the growing cancer institute and other research initiatives. By 1988, more than half the world's liver transplantations were performed in Pittsburgh.9
In 1990, Presbyterian agreed to buy the assets and assume the debt of Montefiore Hospital for $150 million. Montefiore, an adult tertiary hospital adjacent to Pitt, was suffering as a result of the changing reimbursement landscape. Presbyterian, located proximally to Montefiore, was facing capacity constraints and planning to expand. As a result of the acquisition, Presbyterian University Health System, Inc. (PUHSI), Presbyterian Hospital's parent company, gained the right to appoint two thirds of Montefiore's board and manage the hospital; to promote various efficiencies, Eye & Ear was merged into Montefiore. Also in 1990, Pitt's board of trustees approved changing MHCD's name to the University of Pittsburgh Medical Center; in 1992, the Pitt chancellor named one of us (J.A.R.) SVC for health administration and UPMC president.
Separately, the PUHSI board of directors agreed to change its name to UPMC System in 1994. Both the UPMC System hospitals and the Pitt-based hospital management group operated under the UPMC name, and, since then, 16 additional hospital consolidations have occurred under this name. An interesting and important outgrowth of these consolidations was the creation of several new private “conversion” foundations, formed by the transfer of assets from the merging institution to a new nonprofit entity. The largest of these, the Jewish Healthcare Foundation of Pittsburgh, was created with $75 million from the Presbyterian-Montefiore merger. The Eye & Ear Foundation was also created through these mergers.
Not only were hospitals merging, but also, recognizing AHCs' increasing belt-tightening, the SOM began consolidating basic science departments both to eliminate redundancies and to stimulate interdisciplinary collaboration. To house these departments, Pitt built a new, 15-story research building, which was dedicated in 1990.
The Emergence of UPMC
As UPMC was growing, so were national health care expenditures, rising to nearly 14% of the gross domestic product by 1994.1 To achieve economies of scale, to rationalize excess capacity, and to compete in the emerging managed care environment, hospitals consolidated and formed networks. In western Pennsylvania, the two leading health care network organizers were UPMC and the Allegheny Health, Education, and Research Foundation (AHERF). UPMC emerged as what is now a 20-hospital regional system committed to sustaining the first-rate AHC that had been evolving at Pitt. AHERF, in 1998, having amassed $1.3 billion in debt, was declared the largest nonprofit medical system bankruptcy in history, leaving UPMC as the region's only financially robust health care network.10
In bringing community hospitals into its system, UPMC approached each hospital at three levels—(1) the governing board, (2) hospital management, and (3) medical staff—and sought to understand each institution's core culture and values. Although most hospitals needed to merge to survive, they were also seeking a trustworthy partner. UPMC consistently acted to balance the interests of the community-based private practitioners who composed the majority of the medical staffs of the merged community hospitals with those of the SOM clinical departments and faculty who sought to increase their patient volume and market share. For most of the merged hospitals, UPMC implemented a five-year integration period for the transfer of authority, which gave board members, executives, physicians, and staff an opportunity to know one another without the fear of major changes in services or structure and to provide stability during the period of full integration. Unlike the model for many mergers between AHCs and community hospitals, UPMC did not require the appointment of Pitt faculty as clinical department chiefs in the merged hospitals, and UPMC insisted that cases referred for consultation to Pitt faculty remain on the rosters of the referring community physicians. Many community physicians became clinical faculty members in the SOM. The one exception to this model is that many physicians in hospital-based specialties (anesthesiology, pathology, and radiology) became UPMC employees because of their existing hospital employee contractual status as well as UPMC's desire to establish uniform approaches to the standard of care, when possible.
UPMC also introduced the matrix organizational model to the newly integrated hospitals. Under this model, whereas the hospital CEO had responsibility for managing a specific facility, every hospital's administrative and clinical staff reported both to the hospital CEO and to the corporate-level executive who oversaw system-wide operations in their areas of responsibility, just as each hospital's CEO reported to the UPMC president. UPMC applied this model across the board—materials management, purchasing, pharmacy, government relations, communications and marketing, and clinical service lines. UPMC's management team kept cost increases below 1% at a time when health care spending was rising annually about 2.4 percentage points faster than the gross domestic product.11 By creating a truly integrated system, UPMC achieved savings in administrative functions approaching 30%, putting the entire system on sound financial footing.
Although some of the mergers went smoothly, others were fraught with difficulty, reflecting the ambivalence any organization feels when making what it perceives as an identity-transforming change. UPMC faced two particular challenges: (1) melding many, often fiercely independent community hospital cultures and their physician groups into a unified system with shared goals, standards, and values (a far different process than growth from within), and (2) effecting the logistic integration of services required to exert the leverage of scale. However, the five-year integration period gave each hospital's leadership time to understand and adapt to UPMC's highly integrated model.
A shared vision between Pitt and UPMC, underpinned by UPMC's financial acumen, led to the UPMC AHC in its current form. What UPMC's creators did uniquely well was to bring business-like discipline to hospital operations. They also made a firm commitment to supporting research, making the SOM more productive academically, clinically, and economically than ever in its history. Not only did the UPMC clinical enterprise thrive, but, by 1997, Pitt, driven by the SOM, reached and remained among the nation's top 10 NIH-funded universities. Pitt's share of NIH support between 1985 and 1995 grew more rapidly than any other university's. UPMC's growth, integration, and evolution necessitated further redefinition of its role and relationship to Pitt.
In 1997, discussions regarding the form of that relationship began; these discussions culminated in a series of four formal agreements through which the Pitt-based hospital management structure was integrated with the hospitals' parent corporation, which had always been independent. (The parent corporations of Eye & Ear and Montefiore had already become part of PUHSI, which then became UPMC.) All UPMC functions were now independent of, but still intimately affiliated with, Pitt. The agreements include specific provisions related to governance, financial relationships, faculty, identity, and other matters. Particularly important to the SOM's stability is the definition of UPMC's financial commitments to the school in specific dollar amounts rather than as a percentage of UPMC revenue. Thus, UPMC's legal structure and contractual commitment to the SOM are independent of leadership changes or financial swings, although contributions above the mandated amounts may be influenced by either. The agreements became effective in July 1998, have 10-year interdependent terms, and were recently renewed for a second 10-year period with a substantial increase in UPMC's financial commitment to the SOM. Core terms are as follows:
- Reorganization agreement—Transferred certain clinical and administrative functions (e.g., hospital and clinical services management) from Pitt to UPMC; provided for and facilitated development of the unified University of Pittsburgh Physicians (UPP) practice plan by shifting ownership of and responsibility for the individual clinical practice plans from Pitt to UPMC; defined governance mechanisms; addressed asset transfers; and provided assurances that the assets, programs, and practice plan would continue to operate in a manner that advances Pitt's teaching, research, and community service obligations.
- Academic affiliation agreement—Reaffirmed Pitt's and UPMC's commitment to each other and to their interrelated teaching, research, clinical care, and community service missions; defined certain operational features in their ongoing relationship; established the exclusivity of the affiliation with respect to academic and clinical practice matters; and established the financial and operational relationship between UPMC and Pitt with respect to Pitt faculty who perform clinical and also academic duties.
- Trademark license agreement—Described how Pitt permits UPMC to use the name “University of Pittsburgh Medical Center” and the Pitt seal.
- Support services agreement—Identified contract and leasing services, such as building maintenance and communications functions, that may be provided by one entity to the other, and identified how the costs for these services will be determined.
Under the agreements, Pitt designates one third of the UPMC board of directors and its executive committee, whereas the chair of the UPMC board is a member of the Pitt board of trustees. The parties also agreed to provide financial support to each other at a level consistent with prior practice. Table 2 shows UPMC's annual academic contributions to the SOM, which have consistently exceeded the agreement's mandate. In turn, the SOM supplements funds for the other health sciences schools, which function on a different model through which Pitt provides major support but retains a significant proportion of tuition and indirect cost income.
UPMC funding includes academic support for schoolwide research and teaching programs, including a dean's tax on clinical revenues, which is used to support academic activities. As part of this support, UPMC provides the SVC with discretionary funds of almost $40 million per year (used, for example, to support faculty recruitment, innovative pilot research, or major equipment purchases), plus an annual increase. UPMC also provides annual financial support for academic activities directly to the clinical departments and institutes. Thus, in recent years, UPMC has provided an average of $200 million annually to support the SOM, its institutes, and its clinical departments, including facilities construction, clinical-chair-recruitment packages, partial clinical faculty salaries, endowed chairs, and contributions defined by the affiliation agreements.
UPP is the sole practice plan for Pitt medical faculty, and the SOM is the sole medical school for UPMC. Physicians employed by UPP must maintain Pitt faculty appointments, with very few exceptions. Clinical faculty, including clinical department chairs, participate in the SOM/UPP compensation plan. This plan encompasses a common paymaster mechanism, with Pitt and UPMC each providing separate paychecks to faculty members but only one W-2. The collaborative relationship between the leadership teams of both the SOM and UPP has allowed for a structured faculty accountability and incentive system that is aligned to each faculty member's designated role (academic, clinical, research) and agreed-on priorities. UPMC's ownership of the clinical practice plans has been invaluable to the health system's rapid growth by mandating the professional and economic values of quality improvement and ready patient access to evidence-based care by Pitt faculty.
Appointment of department chairs and service chiefs is also accomplished collaboratively, although the dean has exclusive authority for faculty appointments and promotions. Strategic planning is likewise collaborative, particularly in major program areas such as oncology or for initiatives with potential long-term business opportunities such as drug discovery. Appointments to all major clinical leadership positions are discussed collaboratively by the SOM dean and UPMC president. Pitt and UPMC agreed to maximize research collaboration, with all federally funded, peer-reviewed research involving Pitt faculty to be administered through Pitt, which retains responsibility and authority over traditional matters of academic governance, including tenure. This integrated approach has permitted both organizations to structure and reinforce faculty behavior to effectively advance all three traditional academic missions—research, teaching, and patient care—and to begin to develop a fourth mission—entrepreneurship—through which faculty are encouraged to consider the potential commercial viability of their intellectual property.
As community hospitals joined UPMC—including the highly regarded Shadyside Hospital in 1997, UHCP members Magee-Womens Hospital in 1999 and Children's Hospital of Pittsburgh in 2001, and Mercy Hospital, Pittsburgh's traditionally Catholic facility, in 2008—the organization evolved into a fully integrated delivery and financing model, emerging in 2008 with four core operating units supported by a group of system-wide organizational advancement functions (e.g., quality, nursing, ethics, compliance) and business and enterprise services (e.g., human resources, finance, information technology). The four core operating units are the Hospital and Community Services Division (which has clinical care responsibility across the spectrum of care sites, including UPMC's 20 hospitals and extensive network of rehabilitation, home care, senior, and other services), Insurance Services Division (which now covers more than 1.2 million lives), Physician Services Division (which is responsible for the clinical activity of Pitt faculty and for the community-based physicians employed by UPMC), and International and Commercial Services Division (which comprises commercialization initiatives and overseas clinical management and technology ventures). UPMC has adopted best-in-class governance and organizational transparency standards and, in 2006, became the first and only nonprofit health enterprise to voluntarily and fully adopt the stringent requirements of the landmark 2002 Sarbanes–Oxley Act mandating new or enhanced standards for all U.S. public company boards, management, and public accounting firms.
Taking Research and Education to the Next Level
The SVC recognized that whereas most paradigm-shifting medical advances would evolve from the basic sciences, the most immediate and publicly apparent advances would be in clinical and translational research. He focused the SOM's research programs on these areas. By 1997, Pitt had durably reached the ranks of the top 10 NIH-funded institutions, with 21 NIH-supported interdisciplinary centers of excellence, some of which involved not just Pitt but also neighboring Carnegie Mellon University and other partners (List 1). Pitt began to search for an SVC who could build the basic science infrastructure that would advance the institution to the next level of research productivity. The implementation of the affiliation agreements, which outlined the mutual expectations and obligations between UPMC and Pitt, laid important groundwork for a successful search for a successor because the agreements simplified complex organizational relationships by separating the clinical functions of UPMC from the academic functions of Pitt and by codifying and making transparent lines of authority and responsibility, financial commitments, and mutual obligations.
The search ultimately led to one of us (A.S.L.), who became SVC for the health sciences and dean of medicine in 1998. His charge at Pitt was to strengthen the basic sciences while sustaining the clinical research strength and to effect, within the SOM, the economies of scale that UPMC had achieved by integrating core functions across the system. He focused on leadership, faculty, education, research support, and organizational structure (Table 3). At the leadership level, he recruited research-experienced leaders throughout the organization, consistent with best practice in successful research enterprises.12 He reorganized and expanded the existing Office of Research, Health Sciences, to have both a basic and clinical research arm. He expanded centralized administrative support to provide technical assistance to investigators at every rung of the career development ladder. For example, Pitt developed one-site access to online training modules in research conduct and compliance, patient safety, the Health Insurance Portability and Accountability Act, animal care and use, and other compliance issues. Specialized research support staff were hired to organize program project submissions and to seek additional industry-sponsored grants. The Health Sciences Library System hired molecular biologists to assist faculty in using emerging DNA- and protein-analysis databases and other tools. The SVC established a formal Office of Academic Career Development in July 2002 to offer guidance, assistance, and mentoring to members of the health sciences academic community at all levels to achieve their professional potential. This office also played a major role in harmonizing the definition, responsibilities, salary, and benefits for postdoctoral fellows across schools and departments.
Since 1998, the SOM has created four new basic science departments—Immunology, Structural Biology, Computational Biology, and Biomedical Informatics—with planning underway for a Department of Developmental Biology, and the SOM has preferentially hired basic sciences faculty whose research themes foster translational research in priority areas: drug discovery and design, regenerative medicine, cancer and immunology, bioinformatics and computational biology, psychiatry and neuroscience, vaccine development, structural biology, developmental biology, and clinical trials management.
The SOM also revised its rank and tenure policies both to clarify expectations and to emphasize and support research productivity. The tenure clock has been lengthened for faculty who conduct research but also have clinical responsibilities; flexible time-out options for tenure-track faculty accommodate family and personal needs. Strengthened faculty policies provide consistent research incentive plans, and an entrepreneurial leave policy allows faculty members to create start-up companies based on their intellectual property.
Interdisciplinary research and “team science” have been reinforced as the school's cultural norm through the creation of centers and institutes (List 1), as has been common at research institutions nationally.13 These entities provide a physical or virtual environment for topic-specific intellectual interchange and are often important for faculty recruitment and retention. To sustain the pipeline of scientists trained to conduct this new genre of integrated science, the SOM initiated interdisciplinary doctorates in fields such as integrative molecular biology and structural biology/molecular biophysics and required all medical students to complete a four-year research project as a graduation requirement.
The SOM also implemented measures to stop the pipeline from leaking, ensuring that promising young faculty members would not abandon their biomedical research careers for other options. These include several internal pilot funding programs (e.g., a Competitive Medical Research Fund that provides up to $25,000, Clinical and Translational Science Institute pilot grants that require collaborators from both basic and clinical disciplines, and grants for applicants proposing high-risk/high-yield research through the NIH Innovator and Pioneer Awards who have not been funded). Other measures meant to retain excellent faculty researchers are bridge funding for investigators who have to resubmit their NIH applications (NIH has subsequently funded 79% of these investigators) and support for technical help for junior faculty who have demands in their personal lives (such as young children or family illnesses) that would slow down their research productivity.
Since 1998, Pitt's health sciences schools have expanded their facilities to about 4.5 million gross square feet, including the 335,000-square-foot, state-of-the-art Biomedical Science Tower 3, dedicated in the fall of 2005, with another 750,000 gross square feet in the construction and planning stages. Pitt's research development activities foreshadow the June 2006 Association of American Medical Colleges' guidelines on how AHCs can attract, nurture, and support more clinical and translational physician–scientists.14 Although such activities—recognizing and appropriately rewarding team science, requiring more rigorous and mentored postdoctoral training, developing research tracks in all clinical training programs, and educating all medical students and residents in research fundamentals—are by no means unique to Pitt, the partnership with UPMC has enabled their rapid and effective implementation.
To support translational and clinical research, particularly clinical trials, UPMC and the SOM are currently developing a unique clinical research registry as part of Pitt's Clinical and Translational Science Institute, which was established in 2006 with an $83.5 million NIH Clinical and Translational Science Award. This database of patients who are informed about the value of research participation and are willing to be contacted to participate in clinical trials will be embedded in UPMC's interoperable electronic health record system and linked with an ongoing database of current Pitt studies, giving researchers potential access to people who use UPMC's 400 outpatient sites, 20 hospitals, and international venues.
In terms of medical education and residency training, the Pitt–UPMC partnership has provided a vast diversity of settings for clinical and research training, including the medical students' required rotations (e.g., to hospitals and physicians' offices in rural areas of Pennsylvania and to the UPMC-managed Mediterranean Institute for Transplantation and Advanced Specialized Therapies in Palermo, Italy) and mandatory research projects (students have studied topics in the basic sciences, clinical outcomes, health care access, and medical applications of information technology, among others), as well as selective areas of concentration (in subjects such as women's health, neuroscience, and global health). Discretionary funds available to the SVC through the affiliation agreement have enabled the SOM to increase scholarship support, making Pitt both more attractive and more competitive to the best and brightest medical students. The UPMC Office of Graduate Medical Education is supervised jointly by the dean of medicine and UPMC's chief medical officer, both of whom emphasize resident education and training in the context of translational science and evidence-based care.
Pitt and UPMC in 2008—Reflections and Lessons Learned
What began as a regional medical school, one Pitt-managed hospital (WPIC), and a voluntary consortium of five independent, affiliated teaching hospitals has evolved during the past 25 years into a global health enterprise and a leading biomedical education and research institution. The process illuminated several fundamental lessons:
- Both partners must be committed to the academic mission, including research excellence, and both must be willing to invest resources in the achievement of excellence.
- The leaders of both organizations must enjoy a collaborative and seamless working relationship. UPMC and the SOM have worked together to create succession plans that ensure that the momentum of each is sustained.
- UPMC's operational and financial success, as well as its commitment of financial and other resources, has enabled the SOM to continue to build its research programs, especially in the context of the currently constrained NIH appropriation. This research strength, in turn, has been a key element in attracting leading physician–scientists, who play critical roles in both organizations.
- The affiliation agreements between Pitt and UPMC codify the relationship and are durable beyond the current leadership. The clear delineation of roles for Pitt and UPMC contributed significantly to the recruitment of a new SVC; two previous searches had failed, in part, because the roles of the SVC for health administration and the SVC for the health sciences were not clearly distinguished.
- It is critical to protect and ensure accountability for all of the traditional functions of the AHC—research, teaching, and excellent patient care. Pitt and UPMC leaders have clarified expectations by delineating faculty accountability, in terms of each individual's priorities and role, and rewarding faculty members for meeting agreed-on goals and expectations. Both institutions evaluate faculty members who have responsibilities related to both.
- Strong governance and a focus on mission are essential components of a best-in-class relationship.
For UPMC and Pitt, success has been an outcome with many contributing factors: institutional commitment to excellence throughout the entire enterprise—research, education, and clinical care—backed by entrepreneurial investments and initiatives, strong and progressive leadership, strategic and controlled facility and business expansion, and recruitment and retention of personnel with the expertise to ensure sustained results. The shared vision of Pitt and UPMC is grounded in science and in the movement of new biomedical knowledge into clinical practice. All of the partners' intellectual and financial resources are required to span this spectrum.
The authors thank Kathleen Sidorovich and Jennifer Petrie Signore, PhD, University of Pittsburgh Office of the Senior Vice Chancellor for the Health Sciences, and Michael Gaber, Office of the Dean, University of Pittsburgh School of Medicine, for their assistance in compiling data for this article.